Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 129

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 129
---
 Commonwealth System of Higher Education/ Carnegie Mellon University |
| Japan         | Microneedle arrays for cancer therapy applications |      2024189676 | 11/6/2014 | 11/6/2015 |         |           | 11/6/2035 | Pending | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |
| Singapore     | Microneedle arrays for cancer therapy applications |     1002004900T | 11/6/2014 | 11/6/2015 |         |           | 11/6/2035 | Pending | University Of Pittsburgh of The Commonwealth System of Higher Education/ Carnegie Mellon University |

<div align='center'>- 90 -

MANAGEMENT</div>

Directors and Executive Officers

The following table sets forth certain information relating to our directors and executive officers as of the date of this offering circular. Directors of Medicus hold office for a one year term and, unless re-elected, will retire from office at the end of the next annual meeting of the shareholders of Medicus. Unless otherwise stated, the business address of our executive officers and directors is our office address at 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

| Name                             | Age | Position with                                  
 Medicus                                        |
| Dr. Larry Kaiser(1) (5)          |  72 | Director                                       |
| Robert J. Ciaruffoli(1) (2) (3)  |  73 | Director                                       |
| Frank Lavelle(1) (2) (4)         |  75 | Director                                       |
| William L. Ashton(2) (3) (4) (5) |  74 | Director                                       |
| Barry Fishman(4) (5)             |  67 | Director                                       |
| Dr. Sara R. May(2)               |  47 | Director                                       |
| Dr. Raza Bokhari(3)              |  58 | Executive Chairman and Chief Executive Officer |
| Carolyn Bonner                   |  41 | President                                      |
| James Quinlan                    |  61 | Chief Financial Officer                        |
| Dr. Edward Brennan               |  65 | Chief Scientific Officer & Head of R&D Program |
| Dr. Faisal Mehmud                |  50 | Chief Medical Officer                          |

Notes:

(1)Member